CBS and Down syndrome: Our group recently generated direct experimental evidence in support of the Kamoun hypothesis: in Down syndrome fibroblasts (Detroit 531 cells), we demonstrated that pharmacological inhibition of CBS (using the small molecule aminooxyacetate) or silencing of CBS restores the suppressed Complex IV activity to near-normal control levels and improves mitochondrial electron transport and cell proliferation [9].